Mucosal disruption due to use of a widely-distributed commercial vaginal product: Potential to facilitate HIV transmission

AIDS

Volumn 12, Issue 7, 1998, Pages 767-773

  Kilmarx, Peter H ^a,b,d   Limpakarnjanarat, Khanchit ^b   Supawitkul, Somsak ^c   Korattana, Supaporn ^b   Young, Nancy L ^a,b   Parekh, Bharat S ^a   Respess, Richard A ^a   Mastro, Timothy D ^a,b   St Louis, Michael E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b HIV/AIDS Collaboration   (Thailand)

^c Chiang Rai Provincial Health Office   (Thailand)

^d MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Asia; Drug toxicity; Policresulen; Prostitutes; Sexual transmission

Indexed keywords

POLICRESULEN;

ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTITUTION; SEXUAL TRANSMISSION; SUPPOSITORY; THAILAND; UTERINE CERVIX MUCOSA; VAGINA MUCOSA; VIRUS TRANSMISSION;

ADMINISTRATION, INTRAVAGINAL; ADULT; ANTI-INFECTIVE AGENTS; COLPOSCOPY; CRESOLS; DRUG COMBINATIONS; FEMALE; FORMALDEHYDE; HIV INFECTIONS; HUMANS; MUCOUS MEMBRANE; PROSPECTIVE STUDIES; PROSTITUTION; RISK; SUPPOSITORIES; VAGINA; VAGINITIS;

EID: 0032493044     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199807000-00013     Document Type: Article

References (26)

1. Wasserheit JN: Epidemiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992, 19:61-77.
2. Kreiss J, Ngugi E, Holmes K, et al.: Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 1992, 268:477-482.
3. Roddy RE, Cordero M, Cordero C, Fortney JA: A dosing study of nonoxynol-9 and genital irritation, Int J STD AIDS 1993, 4:165-170.
4. Marx PA, Spira AI, Gettie A, et al.: Progesterone implants enhance SIV vaginal transmission and early virus load. Nature Med 1996, 2:1084-1089.
5. Gresenguet G, Kreiss JK, Chapko MK, Hillier SL, Weiss NS: HIV infection and vaginal douching in Central Africa. AIDS 1997, 11:101-106.
6. Brown RC, Brown JE, Ayowa OB: Vaginal inflammation in Africa [letter]. N Engl J Med 1992, 327:572.
7. Irwin K, Mibandumba N, Mbuyi K, Ryder R, Sequeira D: More on vaginal inflammation in Africa [letter]. N Engl J Med 1993, 328:888-889.
8. Dallabetta GA, Miotti PG, Chiphangwi JD, Liomba G, Canner JK, Saah AJ: Traditional vaginal agents: use and association with HIV infection in Malawian women. AIDS 1995, 9:293-297.
9. Grosskurth H, Mosha F, Todd J, et al.: Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995, 346:530-536.
10. The International Working Group on Vaginal Microbicides: Recommendations for the development of vaginal microbicides. AIDS 1996, 10:UNAIDS1-UNAIDS6.
11. Siekmann U, Baxmann U: Prospective randomized double-blind comparative study with vaginally applied Albothyl and metronidazole in bacterial vaginosis. Int J Exp Clin Chemother 1990, 3:1-9.
12. Comparato MR, Lorusso A, Dobarro H, Guglielminetti E, Nahas J: Treatment of vaginal discharge with a polyvalent drug. Obst Y Ginec Lat Americ 1992, 50:259-270.
13. Apelo R, Cunanan RF: Clinical experience with Albothyl in the treatment of leucorrhea. Philippine J Obstet Gynecol 1978, 2:1-4.
14. Belonoschkin B: Clinical use of Nelex in Obstetrics and Gynecology: Report on Ten Years' Experience. Stockholm: Gynecologic Clinic, Sodersjukhuset; 1979: 1-8.
15. Salazar JLP, Loya FJD, Mendoza MG: The trichomonacidal, fungicidal and bactericidal effect of metacresolsulphonic acid-methanal polymer in cervicovaginitis. Ginecologia y Obstetrica de Mexico 1983, 51:42-49.
16. Dassenaike AGS: Study of the Efficacy of Albothyl in the Management of Vaginitis, Cervicitis, and Cervical Erosions. Hong Kong: Science Press; 1988: 1-4.
17. Kayanto M, Sjarifuddin PK: Treatment of vaginitis with Albothyl. Medika J Doctor Pharmacist, Indonesia 1979, 5:1-4.
18. Heinke E, Aldick HJ: Treatment of vaginal discharge with a Mcreosol derivative. Arztl Praxis 1971, 23:1823.
19. Limpakarnjanarat K, Mastro TD, Saisorn S, et al.: Incidence of HIV-1 subtype E in a cohort of female prostitutes in Northern Thailand. X International Conference on AIDS. Yokohama, August 1994 [abstract PCO365].
20. World Health Organization Global Programme on AIDS: Manual for the Standardization of Colposcopy for the Evaluation of Vaginally Administered Products. Geneva: WHO; 1995.
21. Weniger BG, Limpakarnjanarat K, Ungchusak K, et al.: The epidemiology of HIV infection and AIDS in Thailand. AIDS 1991, 5 (suppl 2):S71-85.
22. Awwad JT, Khalil AM, Matar MH, Karam KS: A vaginal cast. J Obstet Gynecol 1993, 13:206-207.
23. Marquez-Monter H, Ortiz-Balderrama S, Lara R: Iatrogenic vaginal membrane exfoliation. Am J Obstet Gynecol 1971, 110:1018-1020.
24. Alexander NJ: Barriers to sexually transmitted diseases. Sci Med 1996, 3:32-41.
25. Mostad SB, Kreiss JK: Shedding of HIV in the genital tract. AIDS 1996, 10:1305-1315.
26. Royce RA, Seña A, Cates Jr W, Cohen MS: Sexual transmission of HIV. N Engl J Med 1997, 336:1072-1078.